JPS62253031A - 健康診断装置 - Google Patents
健康診断装置Info
- Publication number
- JPS62253031A JPS62253031A JP61097250A JP9725086A JPS62253031A JP S62253031 A JPS62253031 A JP S62253031A JP 61097250 A JP61097250 A JP 61097250A JP 9725086 A JP9725086 A JP 9725086A JP S62253031 A JPS62253031 A JP S62253031A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- load
- maximum
- blood pressure
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 claims description 50
- 239000008280 blood Substances 0.000 claims description 50
- 230000036772 blood pressure Effects 0.000 claims description 36
- 238000012545 processing Methods 0.000 claims description 17
- 238000001514 detection method Methods 0.000 claims description 16
- 230000000284 resting effect Effects 0.000 claims description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 28
- 235000012000 cholesterol Nutrition 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 14
- 238000010586 diagram Methods 0.000 description 7
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 6
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108010010234 HDL Lipoproteins Proteins 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 5
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 5
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 2
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 238000002555 auscultation Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 description 2
- 150000002830 nitrogen compounds Chemical class 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
Landscapes
- Measuring And Recording Apparatus For Diagnosis (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61097250A JPS62253031A (ja) | 1986-04-25 | 1986-04-25 | 健康診断装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61097250A JPS62253031A (ja) | 1986-04-25 | 1986-04-25 | 健康診断装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62253031A true JPS62253031A (ja) | 1987-11-04 |
| JPH038767B2 JPH038767B2 (enrdf_load_stackoverflow) | 1991-02-06 |
Family
ID=14187329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61097250A Granted JPS62253031A (ja) | 1986-04-25 | 1986-04-25 | 健康診断装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62253031A (enrdf_load_stackoverflow) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63127738A (ja) * | 1986-11-18 | 1988-05-31 | 竹井機器工業株式会社 | 体力測定システム |
| JPH03176024A (ja) * | 1989-12-05 | 1991-07-31 | Ryotaro Hatsui | 高速省力化健康診断方法並びにその装置 |
| JP2000316815A (ja) * | 1999-05-14 | 2000-11-21 | Nagase & Co Ltd | 健康管理装置 |
| JP2010026855A (ja) * | 2008-07-22 | 2010-02-04 | Omron Healthcare Co Ltd | 健康状態判断装置 |
| JP2014104265A (ja) * | 2012-11-29 | 2014-06-09 | Taisho Pharmaceutical Co Ltd | 近赤外線分光法による疲労の評価方法 |
| JP2014104267A (ja) * | 2012-11-29 | 2014-06-09 | Tokyo Medical Univ | ヒト疲労回復評価法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6770749B2 (ja) * | 2015-07-17 | 2020-10-21 | Ｂｌｕｅ Ｗｙｃｈ合同会社 | 運動能力及び運動の評価システム |
-
1986
- 1986-04-25 JP JP61097250A patent/JPS62253031A/ja active Granted
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63127738A (ja) * | 1986-11-18 | 1988-05-31 | 竹井機器工業株式会社 | 体力測定システム |
| JPH03176024A (ja) * | 1989-12-05 | 1991-07-31 | Ryotaro Hatsui | 高速省力化健康診断方法並びにその装置 |
| JP2000316815A (ja) * | 1999-05-14 | 2000-11-21 | Nagase & Co Ltd | 健康管理装置 |
| JP2010026855A (ja) * | 2008-07-22 | 2010-02-04 | Omron Healthcare Co Ltd | 健康状態判断装置 |
| JP2014104265A (ja) * | 2012-11-29 | 2014-06-09 | Taisho Pharmaceutical Co Ltd | 近赤外線分光法による疲労の評価方法 |
| JP2014104267A (ja) * | 2012-11-29 | 2014-06-09 | Tokyo Medical Univ | ヒト疲労回復評価法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH038767B2 (enrdf_load_stackoverflow) | 1991-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Enright et al. | The 6-min walk test: a quick measure of functional status in elderly adults | |
| Ruiz et al. | Artificial neural network-based equation for estimating VO2max from the 20 m shuttle run test in adolescents | |
| KR100428468B1 (ko) | 건강 상태 판정/표시 장치 | |
| Pober et al. | Development and validation of a one-mile treadmill walk test to predict peak oxygen uptake in healthy adults ages 40 to 79 years | |
| US20030208106A1 (en) | Method of cardiac risk assessment | |
| Austin et al. | Reliability of near-infrared spectroscopy for determining muscle oxygen saturation during exercise | |
| Evans et al. | Method of investigation of the accuracy of four digitally‐displaying heart rate meters suitable for use in the exercising horse | |
| Boraita et al. | Normative values for sport-specific left ventricular dimensions and exercise-induced cardiac remodeling in elite Spanish male and female athletes | |
| Kanniainen et al. | Estimation of physiological exercise thresholds based on dynamical correlation properties of heart rate variability | |
| JPS62253031A (ja) | 健康診断装置 | |
| Montoye et al. | The Estimation of [Vdot] O2max from Maximal and Sub-Maximal Measurements in Males, Age 10–39 | |
| Scott et al. | Development and validation of a PACER prediction equation for VO2peak in 10-to 15-year-old youth | |
| Freene et al. | Criterion Validity of the Older-adults 2-minute Step Test in Community-dwelling Middle-aged Adults | |
| JPH0560926B2 (enrdf_load_stackoverflow) | ||
| JPS61211760A (ja) | コンピユ−タ−による健康診断方法 | |
| JPS62156774A (ja) | 健康診断方法 | |
| JP2003111734A (ja) | 健康情報表示装置 | |
| Yamazaki et al. | Peak aerobic performance and left ventricular morphological characteristics in university students | |
| Stapleton et al. | The influence of an intern-resident staff on the quality of private patient care | |
| Gordon | Medical aspects of treatment: The role of the physician | |
| CN113712559B (zh) | 一种人类应激负荷测量方法及其应用 | |
| JPS62253037A (ja) | 体力診断装置 | |
| Elder | Measuring physical fitness of adults in the primary care setting | |
| US20070135723A1 (en) | Method for measuring a user's cardiorespiratory endurance by a fitness equipment | |
| Baker et al. | Advances in Evaluating Fluid Levels: Bioimpedance in Patients with Kidney Failure |